The nanoparticles are aggregated in glioma through specifically binding with low-density lipoprotein receptor-related protein-1 (LRP-1) highly expressed on the surface of brain microvascular endothelial cells and glioma cells. Here, LRP1 is linked to central nervous system cancer.